Jared Kelly insider trades

Open-market stock purchases and sales by Jared Kelly, Chief Executive Officer at Oncolytics Biotech Inc, from SEC Form 4 filings since Feb 11, 2026.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -5%.

Recent trades

DateStockTradeValue
Jun 1, 2026ONCY Oncolytics Biotech IncBought (not open market)—
Mar 12, 2026ONCY Oncolytics Biotech IncBought$4.8K
Feb 12, 2026ONCY Oncolytics Biotech IncBought$24.8K
Feb 11, 2026ONCY Oncolytics Biotech IncBought$4.7K

Companies traded

  • ONCY Oncolytics Biotech Inc: 3 buys, last Jun 1, 2026

Get free alerts when Jared Kelly files a new trade →